Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD

NCT05468073 is registered in ClinicalTrials.gov with Centre Hospitalier St Anne as lead sponsor.

NCT NCT05468073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05468073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD
Lead sponsor
Centre Hospitalier St Anne
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 11, 2022
Completion date
June 8, 2028
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease